摘要 |
The invention is directed to the ethanedisulfonate salt of trans-4-aminocyclohexyl (lS, 2R, 3S, 4S, 6R, 7R, 8R, 14R )-4-ethenyl-3-hydroxy-2,4J7,14-tetramethyl-9- oxotricyclo[5.4.3.01,8]tetradec-6-yl imidodicarbonate (Compound IA.) Compound IA is use for the treatment of a variety of diseases and conditions, such as respiratory tract and skin an skin structure infections. Accordingly, the invention is further directed to pharmaceutical compositions comprising Compound IA. The invention is still further directed to methods of treating respiratory tract and skin and skin structure infections using Compound IA or a pharmaceutical composition comprising Compound IA.
|